Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV

ClinicalTrials.gov ID: NCT00000791

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00000791. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 1:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the safety and anti-HIV activity of two doses of SC-49483 in combination with zidovudine (AZT) versus AZT alone. To determine the influences of viral phenotype on the anti-HIV activity of these treatment regimens. SC-49483 has no inherent activity against HIV-1 but is converted in the intestinal wall to SC-48334, which has demonstrated anti-HIV activity. Since SC-49483 causes significantly less gastrointestinal toxicity than SC-48334, the combination of SC-49483 with AZT may improve the benefits of both drugs in patients with HIV infection.

Study identification

NCT ID
NCT00000791
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
210 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jul 1995 (Actual)
Last update posted
Oct 28, 2021

Ends 1995

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama — —
USC CRS Los Angeles California 90033 —
Stanford CRS Palo Alto California — —
Ucsf Aids Crs San Francisco California 94110 —
University of Colorado Hospital CRS Aurora Colorado — —
Univ. of Miami AIDS CRS Miami Florida — —
Northwestern University CRS Chicago Illinois 60611 —
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612 —
Weiss Memorial Hosp. Chicago Illinois 60640 —
Cook County Hosp. CORE Ctr. Chicago Illinois — —
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana — —
Methodist Hosp. of Indiana Indianapolis Indiana — —
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri 63112 —
Washington U CRS St Louis Missouri — —
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14260 —
Beth Israel Med. Ctr. (Mt. Sinai) New York New York — —
Univ. of Rochester ACTG CRS Rochester New York — —
Unc Aids Crs Chapel Hill North Carolina 27514 —
Wake County Health and Human Services CRS Raleigh North Carolina — —
Univ. of Cincinnati CRS Cincinnati Ohio — —
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania — —
University of Washington AIDS CRS Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2021 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.